| n | SOD2‡
| Â |
---|
 |  | Average | Variance |
---|
Patient Cohort #1 | Â | Â | Â |
pN +
| 27 | 1.18 | 0.19 |
pN -
| 26 | 1.29 | 0.21 |
 |  |  | (p = 0.043) |
Patient Cohort #2 | Â | Â | Â |
pN +
| 40 | 1.06 | 0.57 |
pN -
| 60 | 1.62 | 0.58 |
 |  |  | (p = 0.0004) |
-
†One-way ANOVA was used to assess the association of SOD2 with pN.
-
‡ The expression levels of SOD2 for Patient Cohort #1 were based on the relative mRNA level. The expression levels of SOD2 for Patient Cohort #2 were generated from Immunohistochemistry. The p-values were computed using one-way ANOVA.